On June 27, 2024, Pfizer Inc. announced the appointment of Cyrus Taraporevala to its Board of Directors, effective immediately. Taraporevala, with a rich background in investment management and financial markets, has previously held the position of President and CEO at State Street Global Advisors and has served in leadership roles at various other financial institutions. His election to the Board also includes appointments to the Audit Committee and the Compensation Committee. Pfizer's Chairman and CEO, Albert Bourla, expressed confidence in Taraporevala's vast experience, which he believes will be an asset to Pfizer and its shareholders. The company highlighted Taraporevala's global operational experience and leadership as key factors that will contribute to Pfizer's mission of delivering breakthroughs that change patients' lives. The formal announcement was made through a press release dated July 1, 2024.

On June 27, 2024, Pfizer Inc. announced the appointment of Cyrus Taraporevala to its Board of Directors, effective immediately. Taraporevala, with a rich background in investment management and financial markets, has previously held the position of President and CEO at State Street Global Advisors and has served in leadership roles at various other financial institutions. His election to the Board also includes appointments to the Audit Committee and the Compensation Committee. Pfizer's Chairman and CEO, Albert Bourla, expressed confidence in Taraporevala's vast experience, which he believes will be an asset to Pfizer and its shareholders. The company highlighted Taraporevala's global operational experience and leadership as key factors that will contribute to Pfizer's mission of delivering breakthroughs that change patients' lives. The formal announcement was made through a press release dated July 1, 2024.